365 related articles for article (PubMed ID: 9153319)
1. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts.
Joseph J; Kandala JC; Veerapanane D; Weber KT; Guntaka RV
Nucleic Acids Res; 1997 Jun; 25(11):2182-8. PubMed ID: 9153319
[TBL] [Abstract][Full Text] [Related]
2. Triple helix formation with the promoter of human alpha1(I) procollagen gene by an antiparallel triplex-forming oligodeoxyribonucleotide.
Nakanishi M; Weber KT; Guntaka RV
Nucleic Acids Res; 1998 Nov; 26(22):5218-22. PubMed ID: 9801322
[TBL] [Abstract][Full Text] [Related]
3. Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages.
Cogoi S; Rapozzi V; Quadrifoglio F; Xodo L
Biochemistry; 2001 Feb; 40(5):1135-43. PubMed ID: 11170438
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter.
Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE
Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472
[TBL] [Abstract][Full Text] [Related]
5. Triple helix-forming oligonucleotide corresponding to the polypyrimidine sequence in the rat alpha 1(I) collagen promoter specifically inhibits factor binding and transcription.
Kovacs A; Kandala JC; Weber KT; Guntaka RV
J Biol Chem; 1996 Jan; 271(3):1805-12. PubMed ID: 8576186
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the formation and intracellular stability of purine.(purine/pyrimidine) triplexes.
Debin A; Malvy C; Svinarchuk F
Nucleic Acids Res; 1997 May; 25(10):1965-74. PubMed ID: 9115364
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
Kim HG; Miller DM
Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
[TBL] [Abstract][Full Text] [Related]
8. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
9. Triplex-induced recombination and repair in the pyrimidine motif.
Kalish JM; Seidman MM; Weeks DL; Glazer PM
Nucleic Acids Res; 2005; 33(11):3492-502. PubMed ID: 15961731
[TBL] [Abstract][Full Text] [Related]
10. Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy.
Shen C; Rattat D; Buck A; Mehrke G; Polat B; Ribbert H; Schirrmeister H; Mahren B; Matuschek C; Reske SN
Cancer Biother Radiopharm; 2003 Feb; 18(1):17-26. PubMed ID: 12667305
[TBL] [Abstract][Full Text] [Related]
11. Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation.
Paramasivam M; Cogoi S; Filichev VV; Bomholt N; Pedersen EB; Xodo LE
Nucleic Acids Res; 2008 Jun; 36(10):3494-507. PubMed ID: 18456705
[TBL] [Abstract][Full Text] [Related]
12. Triplex formation inhibits HER-2/neu transcription in vitro.
Ebbinghaus SW; Gee JE; Rodu B; Mayfield CA; Sanders G; Miller DM
J Clin Invest; 1993 Nov; 92(5):2433-9. PubMed ID: 7901237
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.
Kim HG; Reddoch JF; Mayfield C; Ebbinghaus S; Vigneswaran N; Thomas S; Jones DE; Miller DM
Biochemistry; 1998 Feb; 37(8):2299-304. PubMed ID: 9485376
[TBL] [Abstract][Full Text] [Related]
14. Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.
McGuffie EM; Catapano CV
Nucleic Acids Res; 2002 Jun; 30(12):2701-9. PubMed ID: 12060688
[TBL] [Abstract][Full Text] [Related]
15. An RNA oligonucleotide corresponding to the polypyrimidine region of the rat alpha 1(I) procollagen promoter forms a stable triplex and inhibits transcription.
Ririe SS; Guntaka RV
Biochem Biophys Res Commun; 1998 Aug; 249(1):218-21. PubMed ID: 9705860
[TBL] [Abstract][Full Text] [Related]
16. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
Kim HG; Miller DM
Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
[TBL] [Abstract][Full Text] [Related]
17. Purine- and pyrimidine-triple-helix-forming oligonucleotides recognize qualitatively different target sites at the ribosomal DNA locus.
Maldonado R; Filarsky M; Grummt I; Längst G
RNA; 2018 Mar; 24(3):371-380. PubMed ID: 29222118
[TBL] [Abstract][Full Text] [Related]
18. Targeting of an interrupted polypurine:polypyrimidine sequence in mammalian cells by a triplex-forming oligonucleotide containing a novel base analogue.
Semenyuk A; Darian E; Liu J; Majumdar A; Cuenoud B; Miller PS; Mackerell AD; Seidman MM
Biochemistry; 2010 Sep; 49(36):7867-78. PubMed ID: 20701359
[TBL] [Abstract][Full Text] [Related]
19. Monitoring DNA triplex formation using multicolor fluorescence and application to insulin-like growth factor I promoter downregulation.
Hégarat N; Novopashina D; Fokina AA; Boutorine AS; Venyaminova AG; Praseuth D; François JC
FEBS J; 2014 Mar; 281(5):1417-1431. PubMed ID: 24423253
[TBL] [Abstract][Full Text] [Related]
20. The human c-Src proto-oncogene promoter contains multiple targets for triplex-forming oligonucleotides.
Ritchie S; Bonham K
Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):391-400. PubMed ID: 9826266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]